首页 | 本学科首页   官方微博 | 高级检索  
检索        

黛力新治疗慢性阻塞性肺疾病加重期焦虑抑郁症
引用本文:张国伟,吴绍娴,许荻,杨勇,吴建辉.黛力新治疗慢性阻塞性肺疾病加重期焦虑抑郁症[J].航空航天医药,2010,21(7):1092-1093.
作者姓名:张国伟  吴绍娴  许荻  杨勇  吴建辉
作者单位:广东省电白县人民医院,广东,电白,525400
摘    要:目的:探讨抗焦虑抑郁药物黛力新在对慢性阻塞性肺疾病加重期焦虑抑郁患者中的疗效。方法:对于符合慢性阻塞性肺疾病加重期标准患者,采用汉密尔顿焦虑量表(HAMA)测量心理状况,将患者分为黛力新组及对照组,治疗2周后再检测患者的各项观察指标。结果:治疗2周后两组对比,黛力新组HAMA得分均有降(P〈0.01),COPD加重期各项疗效指标均有明显改善,显效率100%(P〈0.01)。结论:黛力新能改善慢性阻塞性肺疾病加重期患者的焦虑及抑郁症状。

关 键 词:黛力新  慢性阻塞性肺疾病加重期  焦虑症

Application of Deanxit of Anxiety and Depression in COPD with Exacerbation
Institution:ZHANG Guo-wei,WU Shao-xian,XU Di,et al.(The People's Hospital of Dianbai County,Dianbai 525400,China)
Abstract:Objective:To investigate the anti-anxiety drugs deanxit depression on COPD exacerbations of efficacy in patients with anxiety and depression.Methods:For those patients with COPD exacerbation criteria,using the Hamilton Anxiety Scale (HAMA) measure of psychological status,patients were divided into deanxit group and control group,treatment of patients with 2W after detection of the observation target.Results:The treatment groups after 2W contrast deanxit Group HAMA scores were lower (P0.01),COPD exacerbation of the efficacy parameters were significantly improved,markedly effective rate 100% (P0.01).Conclusions:deanxit can improve COPD patients with exacerbation of symptoms of anxiety and depression.
Keywords:Deanxit  COPD exacerbations  Anxiety
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号